CHAF1A and neoplasm: Our data let us envisage novel potential therapeutic approaches for OSCC by blocking the p60 protein, hampering the CAF-1 complex function and inducing HR defects that would sensitize tumour cells to Olaparib and/or in association with ionizing radiation.